Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jonathan Wang and Pablo Moscato

Premium

Response Biomedical said this week that Jonathan Wang has been appointed to the company's board of directors.

Wang was previously a director at Response Biomedical in 2010 and 2011 and serves on the board at ForteBio. He is also senior managing director at Orbimed and a co-founder of that company's Asia-focused venture capital fund. He previously was a GM at Burrill Greater China Group and he worked for other venture capital funds focused on Asia.


University of Newcastle professor Pablo Moscato has received a Future Fellowship from the Australian Research Council.

The A$858,468 (US$902, 745) award will fund his work with memetic algorithms to solve optimization problems in bioinformatics.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.